These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35903906)

  • 1. Colchicine resistance: Associated factors and its effect on health-related quality of life in patients with familial Mediterranean fever.
    Erdem Gürsoy D; Gezer HH; Öz N; Özer A; Acer Kasman S; Duruöz MT
    Int J Rheum Dis; 2022 Nov; 25(11):1239-1245. PubMed ID: 35903906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-interleukin-1 treatment among patients with familial Mediterranean fever resistant to colchicine treatment. Retrospective analysis.
    Sargin G; Kose R; Senturk T
    Sao Paulo Med J; 2019 May; 137(1):39-44. PubMed ID: 31116269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial Mediterranean fever-associated infertility and underlying factors.
    Atas N; Armagan B; Bodakci E; Satis H; Sari A; Bilge NSY; Salman RB; Yardımcı GK; Babaoglu H; Kilic L; Ozturk MA; Goker B; Haznedaroglu S; Kasifoglu T; Kalyoncu U; Tufan A
    Clin Rheumatol; 2020 Jan; 39(1):255-261. PubMed ID: 31502094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The remarkable characteristics of the children with colchicine-resistant familial Mediterranean fever in Turkey.
    Sahin N; Ozdemir Cicek S; Pac Kisaarslan A; Poyrazoglu MH; Gunduz Z; Dusunsel R
    Mod Rheumatol; 2022 Jan; 32(1):177-185. PubMed ID: 33775204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial Mediterranean fever in childhood: a single-center experience.
    Barut K; Sahin S; Adrovic A; Sinoplu AB; Yucel G; Pamuk G; Aydın AK; Dasdemir S; Turanlı ET; Buyru N; Kasapcopur O
    Rheumatol Int; 2018 Jan; 38(1):67-74. PubMed ID: 28828621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can the Thiol/Disulfide Imbalance Be a Predictor of Colchicine Resistance in Familial Mediterranean Fever?
    Omma A; Sandikci SC; Kücüksahin O; Alisik M; Erel O
    J Korean Med Sci; 2017 Oct; 32(10):1588-1594. PubMed ID: 28875601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early predictors of colchicine resistance in familial Mediterranean fever.
    Mosad Mosa D; Shokry D; Ahmed DB; Sobh A
    Mod Rheumatol; 2023 Jul; 33(4):830-835. PubMed ID: 35789271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A score for predicting colchicine resistance at the time of diagnosis in familial Mediterranean fever: data from the TURPAID registry.
    Batu ED; Şener S; Arslanoglu Aydin E; Aliyev E; Bagrul İ; Türkmen Ş; Akgün Ö; Balık Z; Tanatar A; Bayındır Y; Kızıldağ Z; Torun R; Günalp A; Coşkuner T; İşgüder R; Aydın T; Haşlak F; Kasap Cüceoğlu M; Esen E; Akçay U; Başaran Ö; Pac Kısaarslan A; Akal F; Yüce D; Özdel S; Bülbül M; Bilginer Y; Aktay Ayaz N; Sözeri B; Kasapçopur Ö; Ünsal E; Özen S
    Rheumatology (Oxford); 2024 Mar; 63(3):791-797. PubMed ID: 37228026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial mediterranean fever: assessment of clinical manifestations, pregnancy, genetic mutational analyses, and disease severity in a national cohort.
    Bodur H; Yurdakul FG; Çay HF; Uçar Ü; Keskin Y; Sargın B; Gürer G; Yurdakul OV; Çalış M; Deveci H; Aydın Y; Hizmetli S; Çevik R; Karahan AY; Sunar İ; Duruöz MT; Ecesoy H; Günendi Z; Toprak M; Şen N; Altıntaş D; Cengiz AK; Çağlayan G; Demir AN; Kaplan H; Ketenci S; Melikoğlu MA; Nayimoğlu M; Nas K; Sarıfakıoğlu AB; Sezer İ
    Rheumatol Int; 2020 Jan; 40(1):29-40. PubMed ID: 31522233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the efficacy and safety of tocilizumab for colchicine-resistant or colchicine-intolerant familial Mediterranean fever: study protocol for an investigator-initiated, multicenter, randomized, double-blind, placebo-controlled trial.
    Koga T; Sato S; Miyamoto J; Hagimori N; Kawazoe Y; Arinaga K; Fukushima C; Yamamoto H; Kawakami A
    Trials; 2018 Dec; 19(1):715. PubMed ID: 30594222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial Mediterranean fever patients homozygous for E148Q variant may have milder disease.
    Topaloglu R; Batu ED; Yıldız Ç; Korkmaz E; Özen S; Beşbaş N; Özaltın F
    Int J Rheum Dis; 2018 Oct; 21(10):1857-1862. PubMed ID: 27457448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canakinumab is effective in patients with familial Mediterranean fever resistant and intolerant to the colchicine and/or anakinra treatment.
    Karabulut Y; Gezer HH; Duruöz MT
    Rheumatol Int; 2022 Jan; 42(1):81-86. PubMed ID: 34550430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of anti-interleukin-1 treatment on quality of life in children with colchicine-resistant familial Mediterranean fever: A single-center experience.
    Kurt T; Aydın F; Nilüfer Tekgöz P; Sezer M; Uncu N; Çelikel Acar B
    Int J Rheum Dis; 2020 Jul; 23(7):977-981. PubMed ID: 32558310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anakinra for Colchicine-Resistant Familial Mediterranean Fever: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Ben-Zvi I; Kukuy O; Giat E; Pras E; Feld O; Kivity S; Perski O; Bornstein G; Grossman C; Harari G; Lidar M; Livneh A
    Arthritis Rheumatol; 2017 Apr; 69(4):854-862. PubMed ID: 27860460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life in adult patients with Familial Mediterranean fever living in Germany or Turkey compared to healthy subjects: a study evaluating the effect of disease severity and country of residence.
    Giese A; Kurucay M; Kilic L; Örnek A; Şendur SN; Lainka E; Henning BF
    Rheumatol Int; 2013 Jul; 33(7):1713-9. PubMed ID: 23274441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MEFV gene compound heterozygous mutations in familial Mediterranean fever phenotype: a retrospective clinical and molecular study.
    Caglayan AO; Demiryilmaz F; Ozyazgan I; Gumus H
    Nephrol Dial Transplant; 2010 Aug; 25(8):2520-3. PubMed ID: 19934083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of colchicine-resistant Familial Mediterranean fever in children and adolescents.
    Eroglu FK; Beşbaş N; Topaloglu R; Ozen S
    Rheumatol Int; 2015 Oct; 35(10):1733-7. PubMed ID: 26001859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of anti-tumor necrosis factor agents for familial mediterranean fever patients with chronic arthritis and/or sacroiliitis who were resistant to colchicine treatment.
    Bilgen SA; Kilic L; Akdogan A; Kiraz S; Kalyoncu U; Karadag O; Ertenli I; Dogan I; Calguneri M
    J Clin Rheumatol; 2011 Oct; 17(7):358-62. PubMed ID: 21946459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late-onset familial Mediterranean fever in Japan.
    Kishida D; Yazaki M; Nakamura A; Tsuchiya-Suzuki A; Shimojima Y; Sekijima Y
    Mod Rheumatol; 2020 May; 30(3):564-567. PubMed ID: 31116049
    [No Abstract]   [Full Text] [Related]  

  • 20. Work productivity impairment in patients with familial Mediterranean fever and effects of interleukin-1 antagonists.
    Suticen E; Atas N; Guler AA; Akdogan O; Babaoğlu H; Satis H; Karadeniz H; Haznedaroglu S; Ozturk MA; Tufan A
    Clin Rheumatol; 2021 Jul; 40(7):2865-2871. PubMed ID: 33527168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.